Диссертация (1139753), страница 23
Текст из файла (страница 23)
J Rheumatol 2004; 31: 2501–6.143108. Ostring GT, Singh-Grewal D. Juvenile idiopathic arthritis in the new world ofbiologics. J Paediatrics Child Health 2013;49:E405–12.109. P. Woo, t. R. Southwood, et al. Randomized, placebo-controlled, crossover trial ofLow-dose oral methotrexate in children with extended Oligoarticular or systemicarthritis. Arthritis & Rheumatism, Vol.
43, No. 8, August 2000, pp 1849–1857.110. Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P. Prognosis ofjuvenilerheumatoidarthritis-associateduveitis.EurJOphthalmol.2003;13(7):616–21.111. Pay S, Turkcapar N, Kalyoncu M, et al. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis.
ClinRheumatol 2006; 25: 639–44.112. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest.2003; 111 (12): 1805-12.113. Petty RE, Southwood TR, Manners P, et al; International League of Associationsfor Rheumatology classification of juvenile idiopathic arthritis: second revision,Edmonton, 2001. J Rheumatol. 2004 Feb;31(2):390-2.114. PrakkenB, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet.2011;377(9783):2138–2149.115. Prieur AM, Le Gall E, Karman F, Edan C, Lasserre O, Goujard J.
Epidemiologicsurvey of juvenile chronic arthritis in France. Comparison of data obtained fromtwo different regions. Clin Exp Rheumatol. 1987;5(3):217- 23.116. Putschky N, Pott HG, Kuipers JG, Zeidler H, Hammer M, Wollenhaupt J.Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydiatrachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis.2006 Nov; 65(11):1521-4.117. Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, Viola S,Martini A. Patients with antinuclear antibody-positive juvenile idiopathic arthritisconstitute a homogeneous subgroup irrespective of the course of joint disease.Arthritis Rheum.
2005 Mar; 52(3):826-32.144118. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–78.119. Ravelli A, Varnier GC, Oliveira S, et al. Antinuclear antibody-positive patientsshould be grouped as a separate category in the classification of juvenile idiopathicarthritis. Arthritis Rheum 2011; 63:267–275.120. Ravelli A, Viola S, Migliavacca D, Pistorio A, Ruperto N, Martini A.
Discordancebetween proxy-reported and observed assessment of functional ability of childrenwith juvenile idiopathic arthritis. Rheumatology(Oxford). 2001;40(8):914-9.121. Rigante D, Bosco A, Esposito S. The Etiology of Juvenile Idiopathic Arthritis. ClinRev Allergy Immunol. 2015;49:253–261.122.
Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, et al, forthe Pediatric Rheumatology International Trials Organization. A randomized trialof parenteral methotrexate comparing an intermediate dose with a higher dose inchildren with juvenile idiopathic arthritis who failed to respond to standard dosesof methotrexate.
Arthritis Rheum 2004; 50: 2191–201.123. Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, JoosR, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M,Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M,Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S. Аrandomized, double-blind clinical trial of two doses of meloxicam compared withnaproxen in children with juvenile idiopathic arthritis: short- and long-termefficacy and safety results. Arthritis Rheum. 2005 Feb;52(2):563-72.124.
Sarah Ringold, Teresa M. Ward and Carol A. Wallace. Disease Activity andFatigue in Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2013 Mar;65(3): 391–397.125. Sarakbi HA, Hammoudeh M, Kanjar I, Al-Emadi S, Mahdy S, Siam A.Poststreptococcalreactivearthritisandthe associationwithtenosynovitis, and enthesitis. J Clin Rheumatol. 2010 Jan;16(1):3-6.tendonitis,145126.
Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, et al.Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: along-term followup study. Arthritis Rheum. 2007;56(2):647–57.127. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat RevRheumatol. 2011;7:569–578.128. Schutze GE, Willoughby RE, Committee on Infectious Diseases, AmericanAcademy of Pediatrics. Clostridium difficile infection in infants and children.Pediatrics. 2013 Jan; 131(1):196-200.129.
Sen ES, Dick AD, Ramanan AV. Uveitis associated with juvenile idiopathicarthritis. Nat Rev Rheumatol 2015 Jun;11(6):338–348.130. Shapira Y. Geoepidemioligy of autoimmune rheumatic diseases / Y. Shapira, N.Agmon-Levin, Y. Shoenfeld // Nat. Rev. Rheumatol. – 2010. – № 6. – P. 468-476.131. Sheila T. Angeles-Han, Courtney McCracken, et al. Characteristics of a cohort ofchildren with Juvenile Idiopathic Arthritis and JIA-associated Uveitis. PediatrRheumatol Online J.
2015; 13: 19.132. Shulman ST, Ayoub EM. Poststreptococcal reactive arthritis. Curr OpinRheumatol 2002;14:562–5.133. Singh A, Aggarwal A, Chaurasia S, Misra R. Identification of immunogenic HLA-B*27:05 binding peptides of salmonella outer membrane protein in patients withreactive arthritis and undifferentiated spondyloarthropathy. J Rheumatol. 2013Feb;40(2):173-85.134. Sircar D, Ghosh B, Ghosh A, Haldar S. Juvenile idiopathic arthritis. Indian Pediatr.2006 May;43(5):429-33.135. Smith EM, Foster HE, Beresford MW. The development and assessment ofbiological treatments for children. Br J Clin Pharmacol 2014;79:379–94.136. Smolen JS, Landewe R, Breedveld FC.
et al. EULAR recommendations for themanagement of rheumatoid arthritis with synthetic and biological diseasemodifying antirheumatic drugs. Ann Rheum Dis 2010;69:964–75.137. Steinbrocker O., Traeger C.H., Batterman R.C. Therapeutic criteria in rheumatoidarthritis. // J.Am. Med. Assoc. – 1949.- V.140.- P. 659-662.146138. Still G.F. On a form of chronic joint disease in children. Reprinted in Clin Orthop1990;259:4—10.139. Stoll ML, Nigrovic PA, Gotte AC, Punaro M. Clinical comparison of early-onsetpsoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis. Clin ExpRheumatol. 2011; 29:582–588.140. Sullivan KE.
Inflammation in juvenile idiopathic arthritis. Rheum Dis Clin NorthAm. 2007;33(3):365–88.141. Terri H. Finkel, Jin Li, Zhi Wei et al. Variants in CXCR4 associate with juvenileidiopathic arthritis susceptibility. BMC Med Genet. 2016; 17: 24.142. Townes JM, Deodhar AA, Laine ES, Smith K, Krug HE, Barkhuizen A, ThompsonME, Cieslak PR, Sobel J. Reactive arthritis following culture-confirmed infectionswith bacterial enteric pathogens in Minnesota and Oregon: a population-basedstudy. Ann Rheum Dis. 2008 Dec;67(12):1689-96.143. Tuompo R, Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritisfollowing Salmonella infection: a population-based study.
Scand J Rheumatol.2013;42(3):196-202.144. Urakami T, Manki A, Inoue T, Oda M, Tanaka H, Morishima T. Clinicalsignificance of decreased serum concentration of cartilage oligomeric matrixprotein in systemic juvenile idiopathic arthritis. J Rheumatol. 2006 May;33(5):996-1000.145. Uziel Y, Perl L, Barash J et al. Post-streptococcal reactive arthritis in children: adistinct entity from acute rheumatic fever.
Pediatr Rheumatol Online J 2011;9:32.146. Välimäki E1, Aittomäki S, et al. Normal inflammasome activation and lowproduction of IL-23 by monocyte-derived macrophages from subjects with ahistory of reactive arthritis. Scand J Rheumatol. 2013;42(4):294-8.147. Van der Helm-van Mil AH. Acute rheumatic fever and poststreptococcal reactivearthritis reconsidered.
Curr Opin Rheumatol 2010;22:437–42.148. Van Rossum MA1, van Soesbergen RM, Boers M, Zwinderman AH, Fiselier TJ,Franssen MJ, ten Cate R, van Suijlekom-Smit LW, Wulffraat NM, van Luijk WH,Oostveen JC, Kuis W, Dijkmans BA; Dutch Juvenile Idiopathic Arthritis Study147group. Long-term outcome of juvenile idiopathic arthritis following a placebocontrolled trial: sustained benefits of early sulfasalazine treatment. Ann RheumDis. 2007 Nov;66(11):1518-24.149. Varni J.W., Bernstein B.H.
Evaluation and management of pain in children withrheumatic diseases // Rheum. Dis. Clin. North Am. – 1991. – V. 17. – P. 985-1000.150. Wananukul S, Voramethkul W, et al. Prevalence of positive antinuclear antibodiesin healthy children. Asian Pac J Allergy Immunol. 2005;23:153-7.151. Wechalekar MD, Rischmueller M, Whittle S, Burnet S, Hill CL. Prolongedremission of chronic reactive arthritis treated with three infusions of infliximab. JClin Rheumatol. 2010 Mar; 16(2):79-80.152. Wiström J, Norrby SR, et al. Frequency of antibiotic-associated diarrhoea in 2462antibiotic-treated hospitalized patients: a prospective study.
J AntimicrobChemother. 2001 Jan; 47(1):43-50.153. Wong DL, Baker CM. Smiling faces as anchor for pain intensity scales. // Pain.2001 Jan;89(2-3):295-300.154. Zarco Montejo P. Diagnosis and treatment of Chlamydia-induced reactive arthritis.Reumatol Clin. 2012 Mar;8 Suppl 1:S20-5.155. Zeggini E, Donn RP, Ollier WE, Thomson W. Evidence for linkage of HLA loci injuvenile idiopathic oligoarthritis: independent effects of HLA-A and HLA-DRB1.Arthritis Rheum. 2002 Oct; 46(10):2716-20.156. Zeidler H., Hudson A.P.
New insights into Chlamydia and arthritis: Promise of acure? Ann. Rheum. Dis. 2014;73:637–644..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
